BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16640565)

  • 1. Receptor association and tyrosine phosphorylation of S6 kinases.
    Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
    FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of ribosomal protein S6 kinases by ubiquitination.
    Wang ML; Panasyuk G; Gwalter J; Nemazanyy I; Fenton T; Filonenko V; Gout I
    Biochem Biophys Res Commun; 2008 May; 369(2):382-7. PubMed ID: 18280803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitination of ribosomal S6 kinases is independent from the mitogen-induced phosphorylation/activation of the kinase.
    Gwalter J; Wang ML; Gout I
    Int J Biochem Cell Biol; 2009 Apr; 41(4):828-33. PubMed ID: 18786649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
    Benito M; Lorenzo M
    Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytes.
    Wu CY; Hsieh HL; Sun CC; Tseng CP; Yang CM
    J Neurochem; 2008 May; 105(4):1499-512. PubMed ID: 18315570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
    Nebigil CG; Launay JM; Hickel P; Tournois C; Maroteaux L
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2591-6. PubMed ID: 10688905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct activation mechanisms of protein kinase B by growth-factor stimulation and heat-shock treatment.
    Matsuzaki H; Yamamoto T; Kikkawa U
    Biochemistry; 2004 Apr; 43(14):4284-93. PubMed ID: 15065872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C; Sadowski HB; Cooper JA
    Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
    Chen KC; Zhou Y; Zhang W; Lou MF
    Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive diffuse activation of phosphoinositide 3-kinase at the plasma membrane by v-Src suppresses the chemotactic response to PDGF by abrogating the polarity of PDGF receptor signalling.
    Platek A; Vassilev VS; de Diesbach P; Tyteca D; Mettlen M; Courtoy PJ
    Exp Cell Res; 2007 Apr; 313(6):1090-105. PubMed ID: 17335807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.
    Kim SJ; Kim SY; Kwon CH; Kim YK
    Growth Factors; 2007 Apr; 25(2):77-86. PubMed ID: 17852407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal S6 kinase signaling and the control of translation.
    Dufner A; Thomas G
    Exp Cell Res; 1999 Nov; 253(1):100-9. PubMed ID: 10579915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of Src, PDGF receptor, and Akt is involved in IL-1beta-induced ICAM-1 expression in A549 cells.
    Lin CC; Lee CW; Chu TH; Cheng CY; Luo SF; Hsiao LD; Yang CM
    J Cell Physiol; 2007 Jun; 211(3):771-80. PubMed ID: 17299794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism.
    Nemazanyy I; Panasyuk G; Zhyvoloup A; Panayotou G; Gout IT; Filonenko V
    FEBS Lett; 2004 Dec; 578(3):357-62. PubMed ID: 15589845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of S6K2, a novel kinase homologous to S6K1.
    Lee-Fruman KK; Kuo CJ; Lippincott J; Terada N; Blenis J
    Oncogene; 1999 Sep; 18(36):5108-14. PubMed ID: 10490847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
    Broome MA; Hunter T
    Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
    Li X; Brunton VG; Burgar HR; Wheldon LM; Heath JK
    J Cell Sci; 2004 Dec; 117(Pt 25):6007-17. PubMed ID: 15564375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-Raf associates with and regulates platelet-derived growth factor receptor signalling.
    Mahon ES; Hawrysh AD; Chagpar RB; Johnson LM; Anderson DH
    Cell Signal; 2005 Jul; 17(7):857-68. PubMed ID: 15763428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late signals from the PDGF receptors leading to the activation of the p70S6-kinase are necessary for the transition from G1 to S phase in AKR-2B cells.
    Simm A; Hoppe V; Karbach D; Leicht M; Fenn A; Hoppe J
    Exp Cell Res; 1998 Nov; 244(2):379-93. PubMed ID: 9806789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.